NBIX vs TMP
Neurocrine Biosciences Inc (NBIX) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the NBIX and TMP stock pages for the full models.
Not investment advice.